FBLG · FibroBiologics, Inc.
$1.81
+0.05 (+2.84%)
At close · Sep 4
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for one year from the issuance of the condensed consolidated financial statements. While management has implemented plans to obtain additional funding, these plans are not sufficient to alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 31, 2026
Market Cap
$12.98M
Shares
6.66M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 2 | $1.15 | $2 |
| 2026-08-13 | 2 | $1.11 | $2 |
| 2026-08-06 | 2,012 | $0.87 | $1,750 |
| 2026-08-05 | 342 | $0.82 | $280 |
| 2026-08-04 | 4,324 | $0.79 | $3,416 |
| 2026-08-03 | 1,549 | $0.70 | $1,084 |
| 2026-07-31 | 338 | $0.72 | $243 |
| 2026-07-30 | 396 | $0.65 | $257 |
| 2026-07-29 | 364 | $0.64 | $233 |
| 2026-07-24 | 942 | $0.74 | $697 |
| 2026-07-23 | 2,114 | $0.74 | $1,564 |
| 2026-07-22 | 2,651 | $0.77 | $2,041 |
| 2026-07-20 | 3,178 | $0.83 | $2,638 |
| 2026-07-17 | 1,924 | $0.84 | $1,616 |
| 2026-07-14 | 5,137 | $0.86 | $4,418 |
| 2026-07-13 | 3,489 | $0.92 | $3,210 |
| 2026-07-08 | 14 | $0.84 | $12 |
| 2026-07-07 | 607 | $0.87 | $528 |
| 2026-07-02 | 772 | $0.91 | $703 |
| 2026-07-01 | 1,688 | $0.95 | $1,604 |
| 2026-06-30 | 360 | $0.79 | $284 |
| 2026-06-29 | 34,562 | $0.83 | $28,686 |
| 2026-06-24 | 290 | $0.75 | $218 |
| 2026-06-17 | 8,854 | $0.81 | $7,172 |
| 2026-06-16 | 9,536 | $0.89 | $8,487 |
| 2026-06-15 | 3,400 | $0.93 | $3,162 |
| 2026-06-12 | 9,040 | $0.96 | $8,678 |
| 2026-06-11 | 1,295 | $0.95 | $1,230 |
| 2026-06-05 | 1,652 | $1.07 | $1,768 |
Showing 1–29 of 29 settlements
Key facts
CIK
1958777
CUSIP
31573L204
13F (30d)
14 filings
14 filers
Visit website
Investor relations